Patient-reported outcomes in PROSPECT trial (Alliance N1048) – FOLFOX is not a panacea

O'Cathail, S.M., Adams, R., Hawkins, M.A. et al. (3 more authors) (2023) Patient-reported outcomes in PROSPECT trial (Alliance N1048) – FOLFOX is not a panacea. Clinical and Translational Radiation Oncology, 43. 100672. ISSN 2405-6308

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2023 The Authors. This is an open access article under the terms of the Creative Commons Attribution License (CC-BY-NC-ND 4.0).
Keywords: Rectal cancer; Trials; PROSPECT; QoL; Radiotherapy; Chemotherapy; Overtreatment; Guidelines
Dates:
  • Published: November 2023
  • Published (online): 30 August 2023
  • Accepted: 29 August 2023
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Oncology
Depositing User: Symplectic Publications
Date Deposited: 14 Jun 2024 09:11
Last Modified: 14 Jun 2024 09:11
Status: Published
Publisher: Elsevier
Identification Number: 10.1016/j.ctro.2023.100672
Related URLs:
Open Archives Initiative ID (OAI ID):

Download

Export

Statistics


CORE (COnnecting REpositories)